Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2016 Jun 30;85(3):400–407. doi: 10.1111/cen.13119

Table 3.

Correlations between individual tumor marker (glucagon and gastrin) and age, sex, PNETs tumor size, tumor number, tumor location, tumor functional status, AJCC stage, lymph node metastases, and lymphovascular invasion.

Characteristic Glucagon P value Gastrin P value
Age 0.428* 0.098 0.297* 0.191

Tumor size 0.503* 0.067 0.027* 0.906

Tumor number −0.466* 0.069 0.332* 0.141

Sex

(Mean) (SD)
Male 2657.5 (2868.6) 0.051 −20.3 (53.9) 0.876
Female −8.1 (46.7) 251.4 (942.7)

Tumor location

(Mean) (SD)
Head/neck −14.5 (3.5) 0.751 −10.0 (NA) 0.563
Body/tail 1135.2 (2244.6) 4.3 (117.6)

Tumor functional status

(Mean) (SD)
F 389.0 (872.0) 1.000 56.3 (124.7) 0.393
NF 1265.4 (2492.6) 193.3 (864.1)

AJCC stage

(Mean) (SD)
I 1234.0 (2381.1) 0.914 −13.3 (46.8) 0.548
II 1608.0 (3261.4) 162.0 (220.2)

LNM

(Mean) (SD)
Yes −22.7 (29.4) 0.629 188.0 (NA) 0.571
No 2013.0 (3093.7) 43.5 (166.9)

LVI

(Mean) (SD)
Yes 3255.5 (4588.4) 0.267 −70.0 (NA) 0.222
No 915.6 (2097.0) 59.5 (148.5)

PNETs=pancreatic neuroendocrine tumors; AJCC=American Joint Committee on Cancer; F=functioning; NF=non-functioning; LNM=lymph node metastases; LVI=lymphovascular invasion.

*

Spearman correlation